Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

analyst-ratings-and-price-targets-for-cvs-health-a-comprehensive-overview

Analyst Ratings and Price Targets for CVS Health A Comprehensive Overview

Mar 1, 2024

Analysts have shared a range of opinions on CVS Health (NYSE: CVS) over the past three months, from…

Read more

Safeguarding Your Website

Mar 1, 2024

BigScoots — Your Domain Awaits

Read more
wall-street-favorites:-7-penny-stocks-with-strong-buy-ratings-for-february-2024

Wall Street Favorites: 7 Penny Stocks With Strong Buy Ratings for February 2024

Mar 1, 2024

Scores of names in “penny stock territory” (stocks trading for $5 or less per share) go unnoticed among…

Read more
equifax-stock-analyst-insights-and-ratings-overview

Equifax Stock Analyst Insights and Ratings Overview

Mar 1, 2024

Exploring Equifax Stock: Analyst Insights As of February 29, 2024, Equifax (NYSE: EFX) has undergone scrutiny from 13…

Read more
report:-racing-analyst-dale-earnhardt-jr.-leaving-nbc

Report: Racing analyst Dale Earnhardt Jr. leaving NBC

Mar 1, 2024

Jim Dedmon-USA TODAY Sports)

Read more
report:-racing-analyst-dale-earnhardt-jr.-leaving-nbc

Report: Racing analyst Dale Earnhardt Jr. leaving NBC

Feb 29, 2024

Jan 19, 2024; Charlotte, NC, USA; Dale Earnhardt Jr. talks to interviewers during the red carpet at Charlotte…

Read more
analyst-reiterates-optimistic-outlook-on-shoals-technologies-and-initiates-coverage-on-teladoc

Analyst Reiterates Optimistic Outlook on Shoals Technologies and Initiates Coverage on Teladoc

Feb 29, 2024

On February 29, 2024, Derek Soderberg, an analyst at Cantor Fitzgerald, reiterated an optimistic outlook on Shoals Technologies…

Read more
e&p-co.-has-90%-potential-upside,-analyst-says

E&P Co. Has 90% Potential Upside, Analyst Says

Feb 29, 2024

Cormark Securities analyst Garett Ursu shared coverage on New Stratus Energy Inc., giving it a Buy rating. Cormark…

Read more
analyst-ratings-and-price-targets-for-viridian-therapeutics

Analyst Ratings and Price Targets for Viridian Therapeutics

Feb 29, 2024

Analyst Ratings for Viridian Therapeutics on February 28, 2024 In the last quarter, analysts have shared a range…

Read more
mixed-analyst-ratings-and-institutional-interest-in-snowflake

Mixed Analyst Ratings and Institutional Interest in Snowflake

Feb 29, 2024

Wedbush analyst Taz Koujalgi has maintained a Neutral rating on Snowflake (NYSE: SNOW) and has increased the price…

Read more
earnings-update:-relx-plc-(lon:rel)-just-reported-its-annual-results-and-analysts-are-updating-their-forecasts

Earnings Update: RELX PLC (LON:REL) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Feb 28, 2024

It’s been a good week for RELX PLC (LON:REL) shareholders, because the company has just released its latest…

Read more
analysts-have-made-a-financial-statement-on-fortescue-ltd’s-(asx:fmg)-half-year-report

Analysts Have Made A Financial Statement On Fortescue Ltd’s (ASX:FMG) Half-Year Report

Feb 28, 2024

As you might know, Fortescue Ltd (ASX:FMG) recently reported its interim numbers. Results look mixed – while revenue…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 422
  6. 423
  7. 424
  8. 425
  9. 426
  10. 427
  11. 428
  12. ...
  13. 435
  14. »

Posts pagination

Newer posts Page 1 … Page 425 … Page 435 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.